Blog
About

4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Plasma Endothelin-1 Levels in Takayasu’s Arteritis

      , , ,

      Cardiology

      S. Karger AG

      Thrombomodulin, Endothelin-1, Takayasu’s arteritis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We measured plasma endothelin-1 (ET-1) levels in patients with Takayasu’s arteritis to investigate its relationship with the disease activity. We also measured plasma thrombomodulin (TM) levels as a marker of endothelial injury. A significant positive correlation was evident between plasma ET-1 levels and erythrocyte sedimentation rates (ESRs) in patients with Takayasu’s arteritis (r = 0.53, p < 0.005). In contrast, plasma levels of TM did not show a significant correlation with ESRs (r = -0.13). ET-1, secreted in this way during the active stages of Takayasu’s arteritis, may cause constriction and proliferation of vascular smooth muscle cells and, as a result, progression of luminal narrowing of the affected vessels in this disorder.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1996
          1996
          19 November 2008
          : 87
          : 4
          : 303-305
          Affiliations
          Department of Cardiology, Jichi Medical School, Tochigi, Japan
          Article
          177110 Cardiology 1996;87:303–305
          10.1159/000177110
          8793164
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 3
          Categories
          General Cardiology

          Comments

          Comment on this article